Cannabinoids and Endometriosis: What is Behind It?

The World Endometriosis Congress is set to take place online from March 6-10 this year. During the event, I will be presenting several intriguing research projects and findings, including a topic that has garnered significant attention lately – cannabinoids. You might be more familiar with substances like CBD oil or marijuana derived from the cannabis plant, which are used in various forms and contexts. However, it is essential to note that many of their medicinal properties remain unverified.

Today at the World Endometriosis Congress, Dr. Yuval Kaufman from Israel provided valuable insights into the research concerning cannabinoids and their potential impact on endometriosis.

What Are Cannabinoids and How Do They Work?

The cannabis plant and its myriad components have enjoyed a long history of use spanning centuries, serving both as an intoxicating agent and for medicinal purposes. Even Queen Victoria of England is reputed to have employed it to alleviate her period pains.

However, the widespread utility of cannabis owes its complexity to a multifaceted interplay of various substances within the plant. Unfortunately, discerning a singular essence responsible for its diverse effects is not straightforward. The cannabis plant boasts numerous species, each with distinct ingredient concentrations. Among these, a combination of cannabinoids, terpenes, and flavonoids appears to underpin its effects.

Some notable cannabinoids include:

  • THC
  • CBD
  • CBG
  • CBC

Terpenes are:

Flavonoids are:

What do cannabinoids have to do with endometriosis?

What scientific results are already available?

What is Dr. Kaufman researching?

Perspective and (no) recommendation

Dr. med. Nadine Rohloff